| Alzheimer's disease P Scheltens, B De Strooper, M Kivipelto, H Holstege, G Chételat, ... The Lancet 397 (10284), 1577-1590, 2021 | 2010 | 2021 |
| Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis WJ Jansen, R Ossenkoppele, DL Knol, BM Tijms, P Scheltens, ... Jama 313 (19), 1924-1938, 2015 | 1491 | 2015 |
| Neurofilaments as biomarkers in neurological disorders M Khalil, CE Teunissen, M Otto, F Piehl, MP Sormani, T Gattringer, ... Nature Reviews Neurology 14 (10), 577-589, 2018 | 1472 | 2018 |
| A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking CE Teunissen, A Petzold, JL Bennett, FS Berven, L Brundin, M Comabella, ... Neurology 73 (22), 1914-1922, 2009 | 731 | 2009 |
| Diagnostic value of cerebrospinal fluid neurofilament light protein in neurology: a systematic review and meta-analysis C Bridel, WN Van Wieringen, H Zetterberg, BM Tijms, CE Teunissen, ... JAMA neurology 76 (9), 1035-1048, 2019 | 544 | 2019 |
| Macrophages in inflammatory multiple sclerosis lesions have an intermediate activation status D Vogel, EJF Vereyken, JE Glim, PDAM Heijnen, M Moeton, ... Journal of neuroinflammation 10 (1), 1-12, 2013 | 536 | 2013 |
| Diagnostic value of plasma phosphorylated tau181 in Alzheimer’s disease and frontotemporal lobar degeneration EH Thijssen, R La Joie, A Wolf, A Strom, P Wang, L Iaccarino, ... Nature medicine 26 (3), 387-397, 2020 | 519 | 2020 |
| A practical guide to immunoassay method validation U Andreasson, A Perret-Liaudet, LJC van Waalwijk van Doorn, ... Frontiers in neurology 6, 150414, 2015 | 480 | 2015 |
| Blood-based biomarkers for Alzheimer's disease: towards clinical implementation CE Teunissen, IMW Verberk, EH Thijssen, L Vermunt, O Hansson, ... The Lancet Neurology 21 (1), 66-77, 2022 | 465 | 2022 |
| Autoantibodies neutralizing type I IFNs are present in~ 4% of uninfected individuals over 70 years old and account for~ 20% of COVID-19 deaths P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, J Manry, ... Science immunology 6 (62), eabl4340, 2021 | 436 | 2021 |
| The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers N Mattsson, U Andreasson, S Persson, H Arai, SD Batish, S Bernardini, ... Alzheimer's & Dementia 7 (4), 386-395. e6, 2011 | 426 | 2011 |
| CSF biomarker variability in the Alzheimer's Association quality control program N Mattsson, U Andreasson, S Persson, MC Carrillo, S Collins, S Chalbot, ... Alzheimer's & Dementia 9 (3), 251-261, 2013 | 397 | 2013 |
| Perspectives on ethnic and racial disparities in Alzheimer's disease and related dementias: update and areas of immediate need GM Babulal, YT Quiroz, BC Albensi, E Arenaza-Urquijo, AJ Astell, ... Alzheimer's & Dementia 15 (2), 292-312, 2019 | 372 | 2019 |
| Conversion from clinically isolated syndrome to multiple sclerosis: a large multicentre study J Kuhle, G Disanto, R Dobson, R Adiutori, L Bianchi, J Topping, ... Multiple Sclerosis Journal 21 (8), 1013-1024, 2015 | 370 | 2015 |
| Optimizing patient care and research: the Amsterdam Dementia Cohort WM van der Flier, YAL Pijnenburg, N Prins, AW Lemstra, FH Bouwman, ... Journal of Alzheimer's disease 41 (1), 313-327, 2014 | 368 | 2014 |
| Standardization of preanalytical aspects of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: a consensus paper from the Alzheimer's Biomarkers … H Vanderstichele, M Bibl, S Engelborghs, N Le Bastard, P Lewczuk, ... Alzheimer's & Dementia 8 (1), 65-73, 2012 | 361 | 2012 |
| Inflammation markers in relation to cognition in a healthy aging population CE Teunissen, MPJ Van Boxtel, H Bosma, E Bosmans, J Delanghe, ... Journal of neuroimmunology 134 (1-2), 142-150, 2003 | 350 | 2003 |
| Cerebrospinal fluid markers for differential dementia diagnosis in a large memory clinic cohort NSM Schoonenboom, FE Reesink, NA Verwey, MI Kester, CE Teunissen, ... Neurology 78 (1), 47-54, 2012 | 341 | 2012 |
| Recommendations to standardize preanalytical confounding factors in Alzheimer’s and Parkinson’s disease cerebrospinal fluid biomarkers: an update M Del Campo, B Mollenhauer, A Bertolotto, S Engelborghs, H Hampel, ... Biomarkers in medicine 6 (4), 419-430, 2012 | 334 | 2012 |
| Cerebrospinal fluid levels of the synaptic protein neurogranin correlates with cognitive decline in prodromal Alzheimer's disease H Kvartsberg, FH Duits, M Ingelsson, N Andreasen, A Öhrfelt, ... Alzheimer's & Dementia 11 (10), 1180-1190, 2015 | 327 | 2015 |
